Health: Novartis’ meningitis B vaccine wins breakthrough therapy status in U.S.
(Reuters) – Novartis said U.S. health regulators have granted the Swiss drugmaker’s meningitis B vaccine Bexsero breakthrough therapy status. The Basel-based company in a statement
Read more